News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023
News Daily News CT Angiography Is Increasing in England, but Downstream Tests Are Not Michael O'Riordan January 12, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE Todd Neale November 05, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Conference News ESC 2022 Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms Yael L. Maxwell August 31, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT Caitlin E. Cox July 08, 2022
News Daily News Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes Todd Neale July 04, 2022
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Conference News ISC 2022 CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy Todd Neale February 11, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Conference News AHA 2021 GIRAF: Cognitive Outcomes Similar With Dabigatran, Warfarin in Older AF Patients Todd Neale November 14, 2021